Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
American Journal of Obstetrics and Gynecology|June 1, 1991
Oral contraceptives and antithrombin III: variations by dosage and ABO blood groupR T Burkman, W R Bell, H A Zacur, et al.
Analytical Biochemistry|October 1, 1987
Deglycosylation of a native, protease-sensitive glycoprotein by peptide N-glycosidase F without protease inhibitorsB G Langer, S K Hong, C H Schmelzer, et al.
Blood|August 1, 1986
Studies on the pathophysiology of posttransfusion purpuraT S Kickler, P M Ness, J H Herman, et al.
Surgery|May 1, 1980
Respiratory failure in acute pancreatitis: the role of free fatty acidsT Kimura, J K Toung, S Margolis, et al.
Thrombosis Et Diathesis Haemorrhagica|June 30, 1975
The phase II urokinase-streptokinase pulmonary embolism trial: a national cooperative studyA A Sasahra, W R Bell, T L Simon, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1979
Accuracy of screening for pulmonary embolism in the emergency roomT L Guidotti, L F Fries, W R Bell, et al.
The Journal of Biological Chemistry|October 15, 1988
Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibersB G Langer, J W Weisel, P A Dinauer, et al.
Contraception|November 1, 1989
Oral contraceptives and lipids and lipoproteins: Part I--Variations in mean levels by oral contraceptive typeR T Burkman, H A Zacur, A W Kimball, et al.
The Journal of Biological Chemistry|September 5, 1989
Fibrinogen sialic acid residues are low affinity calcium-binding sites that influence fibrin assemblyC V Dang, C K Shin, W R Bell, et al.
Contraception|December 1, 1989
Oral contraceptives and lipids and lipoproteins: Part II--Relationship to plasma steroid levels and outlier statusR T Burkman, H A Zacur, A W Kimball, et al.
Pageof 17